Figure 3
Kaplan-Meier plots with log rank test of overall survival (OS). Overall survival of 88 patients in relation to KIF26B expression levels (A) or Ki67 expression levels (B) determined by immunohistochemical staining of tissue microarrays. OS is significantly lower in patients with tumors expressing high levels of both KIF26B and Ki67 than that in patients with tumors expressing low levels of both KIF26B and Ki67 (C).